223 related articles for article (PubMed ID: 19094243)
21. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
22. Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population.
Srivastava P; Gangwar R; Kapoor R; Mittal RD
Dis Markers; 2010; 29(1):37-46. PubMed ID: 20826916
[TBL] [Abstract][Full Text] [Related]
23. No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China.
Jin X; Kuang G; Wei LZ; Li Y; Wang R; Guo W; Wang N; Fang SM; Wen DG; Chen ZF; Zhang JH
World J Gastroenterol; 2005 Apr; 11(16):2385-9. PubMed ID: 15832405
[TBL] [Abstract][Full Text] [Related]
24. Association of Matrix Metalloproteinase1-1607 1G>2G Polymorphism and Lung Cancer Risk: An Update by Meta-Analysis.
Ma Y; Yang X; Xie YP; Yi C; Zhao F; Huang Y
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1841-1847. PubMed ID: 31244308
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.
Wenham RM; Calingaert B; Ali S; McClean K; Whitaker R; Bentley R; Lancaster JM; Schildkraut J; Marks J; Berchuck A
J Soc Gynecol Investig; 2003 Sep; 10(6):381-7. PubMed ID: 12969782
[TBL] [Abstract][Full Text] [Related]
26. MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis.
Xiao XY; Wang XD; Zang DY
Tumour Biol; 2012 Dec; 33(6):2385-92. PubMed ID: 22965879
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-1 mitral expression and -1607 1G/2G gene promoter polymorphism in mitral chordae tendinae rupture.
Lin TH; Yang SF; Chiu CC; Su HM; Wang CL; Voon WC; Lai WT; Sheu SH
Transl Res; 2013 May; 161(5):406-13. PubMed ID: 23116893
[TBL] [Abstract][Full Text] [Related]
29. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC
Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244
[TBL] [Abstract][Full Text] [Related]
30. MMP1-1607(1G>2G) polymorphism and the risk of lung cancer in Lebanon.
Fakhoury H; Noureddine S; Chmaisse HN; Tamim H; Makki RF
Ann Thorac Med; 2012 Jul; 7(3):130-2. PubMed ID: 22924069
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
[TBL] [Abstract][Full Text] [Related]
32. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
[TBL] [Abstract][Full Text] [Related]
33. Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer.
Tsai TH; Wang YM; Chang WS; Tsai CW; Wu HC; Hsu HM; Wang YC; Li HT; Gong CL; Bau DT; Li CY
Anticancer Res; 2018 Sep; 38(9):5159-5164. PubMed ID: 30194163
[TBL] [Abstract][Full Text] [Related]
34. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
35. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
36. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
37. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
38. Association of matrix metalloproteinase family gene polymorphisms with lung cancer risk: logistic regression and generalized odds of published data.
Li H; Liang X; Qin X; Cai S; Yu S
Sci Rep; 2015 Jul; 5():10056. PubMed ID: 26198673
[TBL] [Abstract][Full Text] [Related]
39. Association of MMP8 gene variation with an increased risk of malignant melanoma.
Dębniak T; Jakubowska A; Serrano-Fernández P; Kurzawski G; Cybulski C; Chauhan SR; Laxton RC; Maleszka R; Lubinski J; Ye S
Melanoma Res; 2011 Oct; 21(5):464-8. PubMed ID: 21642878
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
